GLP‑1 drugs appear to change how much we want to eat, and how strongly food “pulls” on the brain. Newer oral versions may ...

GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

Early evidence suggests some patients may find it easier to reduce compulsive behaviours, such as smoking, while others could ...

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress ...

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite—it directly alters brain circuits that control motivation and reward.

Most people do not use one drug, but many. SUDs often involve different substances, but the underlying problem is really one ...

Add Yahoo as a preferred source to see more of our stories on Google. Your memories are likely stored in ensembles of neurons that fire together. PASIEKA/Science Photo Library via Getty Images ...

Drug addiction poses a global public health challenge, with limited therapeutic options and modest efficacy. While numerous studies have shown that social status profoundly impacts mental health and ...

University of Virginia researchers have shown that newer oral GLP-1 weight-loss drugs directly alter brain circuits tied to motivation and reward, not just appetite. These medications engage a pathway ...